Nutrition in Pregnancy & Lactation

Citation model. Claims grounded in AllNutrition's trust-scored library carry an inline bracketed reference [n] linking to the References section, which lists each source's evidence level and AllNutrition trust score (0–1). Where an AllNutrition query returned an overall evidence_strength and consensus_level, those labels are surfaced in the Evidence Review so readers can calibrate confidence. Only sources actually returned by the tool are cited; no trust scores are invented.

---

1. Introduction

Pregnancy and lactation compress a lifetime's worth of nutritional stakes into roughly two years. A single organ — the placenta — must supply, in real time, every substrate a rapidly dividing fetus needs, while the maternal body expands blood volume, remodels metabolism toward insulin resistance, and prepares to lactate. Nutritional adequacy or deficiency in this window can alter neurodevelopment, birth defects, and — through the Developmental Origins of Health and Disease (DOHaD) framework — chronic disease risk manifesting decades later.

This module is also a case study in evidence calibration. Few areas of nutrition contrast so sharply between rock-solid, guideline-anchored interventions (folic acid, iodine sufficiency) and heavily marketed, contested ones (many "prenatal superfood" supplements, high-dose DHA for IQ gains). A physician who cannot distinguish "give this to essentially everyone" from "the trial evidence is genuinely mixed" will either under-treat a preventable birth defect or over-promise a supplement's benefit. This module builds that discriminating judgment.

2. Learning Objectives

By the end of this module, the learner will be able to:

1. Explain the DOHaD/Barker hypothesis and the mechanisms (epigenetic programming, fetal hyperinsulinemia, hypothalamic programming) by which the intrauterine environment shapes lifelong disease risk.
2. State dose, timing, and population-specific recommendations for folic acid, iodine, iron, vitamin D, and choline, and explain why evidentiary strength differs across them.
3. Critically appraise the mixed RCT evidence for omega-3/DHA supplementation, distinguishing established benefits (preterm birth in deficient women) from unproven ones (population-wide neurodevelopmental gains).
4. Apply gestational weight gain guidelines and medical nutrition therapy for gestational diabetes mellitus (GDM).
5. Counsel on food safety (listeria, methylmercury), caffeine, and alcohol using risk-benefit rather than blanket prohibition.
6. Adapt counseling for special populations — vegetarian/vegan pregnancy, multiple-micronutrient supplementation in low-resource settings, and lactation.

3. Scientific Foundations

3.1 Developmental programming: the Barker hypothesis and DOHaD

DOHaD proposes that the fetus adapts to its intrauterine environment through developmental plasticity, calibrating metabolism and organ structure to a predicted postnatal environment. When that prediction is wrong — a fetus programmed for scarcity born into abundance — the adaptations become maladaptive, raising risk for insulin resistance and cardiovascular disease [4], chiefly via epigenetic programming (DNA methylation) [3]. Dutch Hunger Winter cohorts link in-utero famine to higher adult BMI and triglycerides via DNA methylation [3]. The Pima Indian sibling design found ~80% of gestational-diabetes-exposed offspring developed type 2 diabetes by age 25–30 versus ~10% of unexposed siblings, isolating the intrauterine effect from shared genetics [1]. Maternal hyperglycemia drives fetal hyperinsulinemia and macrosomia [1]; maternal undernutrition can permanently reduce nephron and beta-cell endowment [2]. The relationship is U-shaped — both under- and overnutrition carry programming risk [2][5].

3.2 Folic acid and neural tube defect prevention

Standard guidance is 400 mcg/day, starting at least one month preconception and continuing through the first trimester, since the neural tube closes within 21–28 days of gestation — often before pregnancy is recognized. Women with a prior NTD-affected pregnancy are advised 4,000 mcg/day, as a separate supplement (to avoid excess vitamin A from multiple multivitamins) [6]. China's 2009 fortification program was associated with better cognitive/mental-health outcomes in girls aged 10–15, evidence of durable population-level benefit [7]. Two caveats: in one Ethiopian cohort, 61% of women had sub-protective folate levels despite fortification, tracking with parity ("maternal depletion") [8]; and high intake (dietary >435 mcg/day, or sustained supplemental ≥800 mcg/day absent a high-risk indication) has been associated with increased GDM risk — a U-shaped signal against reflexive megadosing [9][6]. Choline/betaine show an independent, smaller-evidence association with lower NTD risk [18].

3.3 Iron and anemia

Iron requirements roughly double in pregnancy. MMS raises hemoglobin more than iron-folic acid (IFA) alone (mean difference ~0.67 g/dL) [10], and high adherence (≥90%) to iron-containing supplements is associated with modestly higher birth weight and reduced low-birth-weight/SGA risk [11]. Each 10 µmol/L increase in early-pregnancy serum iron correlated with 21% lower pre-eclampsia risk in one cohort [12] — an observational signal, not proof that supplementation prevents pre-eclampsia. A practical failure mode: screening-based strategies (supplement only if ferritin <70 µg/L) can underperform if identified women rely on standard prenatal vitamins containing only ~15 mg iron, well below the 40–60 mg/day needed to correct depletion [14][11].

3.4 Iodine and neurodevelopment

Iodine drives fetal thyroid-hormone-dependent neuronal proliferation and migration. A dose-response meta-analysis found suboptimal maternal iodine associated with modest decrements in cognitive (Hedges' g = −0.22), motor (−0.17), and language (−0.16) outcomes, and 19% higher odds of adverse neurodevelopment overall [15]. The relationship is U-shaped: both deficiency and excess impair outcomes, with modeled optimum around 150–300 µg/day [15][16]. Excess iodine can trigger the Wolff-Chaikoff effect and worsen autoimmune thyroid disease [16]. Vegan/vegetarian women are a flagged risk group since iodized salt alone may not suffice; targeted supplementation (~150 µg/day) is commonly recommended [17].

3.5 Vitamin D

Evidence is directionally supportive but inconsistent in magnitude. In GDM, supplementation improves fasting/postprandial glucose, HOMA-IR, and lipids across multiple systematic reviews [19]. For pre-eclampsia, some meta-analyses report 35–63% risk reductions with supplementation before 20 weeks, while a 2024 Cochrane-level review found no clear benefit — genuinely controversial evidence [16]. A post-hoc RCT analysis found high-dose prenatal vitamin D3 associated with improved verbal and visual memory at age 10, an effect not apparent at age 2.5, suggesting some cognitive effects may only emerge later — though this is a single analysis requiring replication [45].

3.6 Choline and brain development

Choline is a precursor for acetylcholine and membrane phospholipids and a methyl donor in fetal epigenetic programming. Roughly 90% of pregnant women fail to meet the 450–550 mg/day adequate intake, since choline concentrates in animal foods (egg yolk, liver) and is largely absent from prenatal vitamins [18]. Higher maternal intake correlates with faster infant information-processing speed and better visual memory [18]. The evidence, while mechanistically compelling, remains narrower than for folate or iodine — an emerging, not established, recommendation.

3.7 Omega-3/DHA: narrow established benefit, unproven broad benefit

The clearest benefit is in women with low baseline omega-3 status: supplementation reduced early preterm birth from ~3.16% to 0.73% in one analysis, and a cost-effectiveness model projected substantial preventable preterm births from targeted testing/supplementation [20]. DHA is the dominant structural fatty acid accreted by the fetal brain/retina in the third trimester. For neurodevelopmental outcomes in unselected populations, results are inconsistent: a trial of algal DHA in Indian mothers with concurrent deficiencies found no neurodevelopmental improvement [21], and reviews describe benefits in healthy children as "modest and inconsistent," most reliable in at-risk subgroups (e.g., ADHD) [21]. Notably, an animal study found high-dose prenatal omega-3 induced autism-like social deficits in offspring — a non-linear, dose-sensitive signal against "more is always better" [22]. The population-wide "boosts IQ" marketing claim outstrips the trial evidence.

3.8 Calcium and pre-eclampsia

Calcium reduces pre-eclampsia risk, especially with low dietary intake (<800 mg/day); a network meta-analysis of 22 RCTs (>36,000 participants) found calcium and several other supplement combinations superior to placebo [23]. WHO recommends 1,500–2,000 mg/day in low-intake settings, but trial data from India/Tanzania found 500 mg/day non-inferior — significant for LMIC implementation cost [24]. As with vitamin D, a recent Cochrane-level review found no overall pre-eclampsia effect, reflecting persistent inconsistency in this literature [24].

3.9 Gestational weight gain

IOM BMI-stratified targets remain the reference: ~12.5–18 kg (underweight), 11.5–16 kg (normal), 7–11.5 kg (overweight), 5–9 kg (obese). Excessive gain is linked to cesarean delivery, macrosomia, and postpartum/childhood obesity; inadequate gain to SGA infants and preterm birth [30]. Most women with BMI ≥18.5 do not achieve guideline-concordant gain in practice [26]. Behavioral counseling, diet-quality improvement, and MMS each show evidence of shifting gain toward target ranges, particularly in LMIC settings [25].

3.10 Gestational diabetes: medical nutrition therapy

Medical nutrition therapy (MNT) is first-line, controlling glycemia without pharmacotherapy in an estimated 70–90% of women [1]. Low glycemic-load diets and higher fiber (each 10 g/day increment linked to 26% lower GDM risk observationally) outperform generic advice on glucose control [27]. Glucose monitoring around meals allows individualized carbohydrate titration against ADA targets (fasting <95 mg/dL; 1-hr postprandial <140; 2-hr <120) [1]. Earlier meal timing is associated with better overnight glucose control, though time-restricted eating is not established as safe in pregnancy [28].

3.11 Food safety: listeria and methylmercury

Pregnancy-associated immune changes increase listeria susceptibility; standard guidance avoids unpasteurized dairy/soft cheeses, undercooked deli meats, refrigerated pâtés, and raw sprouts, since listeria uniquely grows at refrigeration temperatures and crosses the placenta. Fish is a genuine risk-benefit tradeoff, not a simple avoidance rule: guidance recommends 2–3 servings/week of low-mercury fish (salmon, cod, pollock, shrimp, light tuna), avoiding high-mercury species (king mackerel, swordfish, shark, tilefish, bigeye tuna). A UK study argued current guidance may be overly complex relative to actual risk, since fish's nutritional benefit likely outweighs low-level mercury exposure for most women [30]. International toxicological reference values for methylmercury are reasonably consistent, though underlying epidemiological data are largely decades old, and some high-fish-consuming subpopulations exceed exposure limits even while meeting omega-3 targets [29][36].

3.12 Caffeine and alcohol

Caffeine: the standard safe threshold is ≤200 mg/day (~two 8-oz coffees). Evidence is more consistent for high intake (>500 mg/day), linked to lower birth weight and altered fetal sleep states, than for moderate intake [31]. Alcohol: no safe threshold exists. Prenatal alcohol exposure directly causes Fetal Alcohol Spectrum Disorder; guidance is total abstinence from conception attempt onward, since damage can occur before pregnancy is recognized [32] — one of the few genuinely categorical (non-dose-graded) recommendations in this module.

3.13 Nausea and vomiting of pregnancy

Vitamin B6 (1.3–1.4 mg/day; UL 45 mg/day) and ginger are the two dietary interventions with real evidence support; ginger's gingerols/shogaols have documented prokinetic/antispasmodic effects [33]. A content analysis of popular online advice found fewer than 10% of circulating recommendations were evidence-supported and ~5% potentially unsafe — illustrating the gap between online advice and actual evidence [33][34].

3.14 Multiple-micronutrient supplementation in LMICs

MMS (~15 micronutrients near RDA levels) consistently outperforms IFA alone in LMICs, reducing low-birth-weight and SGA risk and improving maternal hemoglobin [10][11], informing WHO's updated guidance considering MMS as an IFA alternative [10]. Effectiveness is adherence- and context-dependent: one rural Niger trial found no birth-weight advantage over IFA, suggesting energy-protein deficits, not micronutrients alone, can be the binding constraint in some settings [10].

3.15 Vegetarian/vegan pregnancy

Vitamin B12 deficiency is the single most consequential risk in vegan (and, to a lesser extent, vegetarian) pregnancy, since B12 occurs reliably only in animal foods. Deficiency risks neurological damage in mother and infant and can be masked hematologically by high folate intake (the "folate trap"), making biomarkers (methylmalonic acid, holotranscobalamin) more reliable than serum B12 alone [37]. A systematic review found vegan-pregnancy infants had significantly lower birth weight than infants of omnivorous mothers [35]. Iron, iodine, choline, vitamin D, calcium, and long-chain omega-3s are secondary but real risks requiring deliberate planning [36][37].

3.16 Lactation nutrition

Lactating women have elevated requirements for energy, fiber (>30 g/day), folate, iodine, vitamin C, calcium, and iron, with vitamin D, E, iodine, and zinc commonly under-consumed in practice [46]. Maternal diet shapes breast milk unevenly: total energy/protein/carbohydrate content is relatively buffered by maternal homeostasis, but fatty-acid profile, micronutrient concentrations, and the milk microbiome are directly diet-responsive — higher maternal PUFA intake raises milk n-3 content, while ultra-processed/high-sugar diets are linked to lower Bifidobacterium abundance [39][38]. Human milk oligosaccharide diversity correlates with maternal fiber, polyphenol, and vitamin D/C/K intake [38].

3.17 Maternal diet and allergy prevention

This is an area where evidence has reversed prior practice. Major guidelines (e.g., ASCIA) now recommend against maternal allergen avoidance during pregnancy or lactation [41]. Instead, early introduction of allergenic solids around 6 months (not before 4 months) is the strongest evidence-backed strategy: the LEAP trial (6 g/week peanut protein) reduced peanut allergy by 81% in high-risk infants, replicated by the EAT trial [40]. Adherence remains limited by parental fear and inconsistent counseling [40]. Maternal Mediterranean-diet adherence during pregnancy/lactation correlates with lower offspring food-allergy risk in cohort data — a softer, observational signal compared to the trial-grade evidence for early infant introduction [43].

4. Clinical Relevance

Nutrition counseling in pregnancy is among the highest-frequency, highest-trust touchpoints in obstetric and primary care, delivered to patients bombarded with conflicting supplement marketing during a period of heightened risk-aversion. The clinician's task is triage: some interventions (folic acid, iodine sufficiency, alcohol abstinence, safe caffeine limits, early allergen introduction) rest on evidence strong enough that hedging undermines trust; others (population-wide DHA for IQ gains, most "prenatal superfood" claims, some pre-eclampsia micronutrient claims) warrant explicit acknowledgment of uncertainty. Over-claiming on weak evidence, once discovered, erodes trust in the genuinely strong recommendations too.

5. Evidence Review

Established (high confidence):

• Periconceptional folic acid prevents neural tube defects; fortification reduces population prevalence. evidence_strength: strong, consensus_level: moderate [6][7][8].
• Iodine sufficiency is necessary for fetal neurodevelopment; deficiency and excess both impair outcomes. evidence_strength: strong, consensus: moderate [15][16].
• No safe alcohol threshold exists. evidence_strength: strong, consensus: moderate [32].
• MMS outperforms IFA alone for low birth weight and maternal hemoglobin in LMICs. evidence_strength: strong, consensus: moderate [10][11].
• Early allergen introduction (~6 months) reduces infant food allergy risk; maternal avoidance does not. evidence_strength: strong, consensus: moderate [40][41].
• Vitamin B12 supplementation is required in vegan pregnancy. evidence_strength: strong, consensus: moderate [35][37].

Probable:

• Omega-3/DHA reduces early preterm birth specifically in low-omega-3-status women. evidence_strength: moderate, consensus: moderate [20].
• Iron reduces maternal anemia and low birth weight; preterm-birth evidence is less consistent. evidence_strength: strong, consensus: moderate [11][12].
• Low-glycemic-load, high-fiber MNT is effective first-line GDM management. evidence_strength: strong, consensus: moderate [27][28].
• Vitamin D improves glycemic control in diagnosed GDM. evidence_strength: strong, consensus: mixed [19].

Emerging:

• Choline's role in fetal brain programming and possible NTD risk reduction alongside folate. evidence_strength: moderate, consensus: moderate [18].
• Earlier meal timing improving overnight glycemic control in GDM. evidence_strength: moderate, consensus: moderate [28].
• Lower-dose (500 mg/day) calcium as non-inferior to WHO's 1,500–2,000 mg/day for pre-eclampsia in LMIC trials. evidence_strength: moderate, consensus: mixed [24].

Controversial:

• Calcium and vitamin D for pre-eclampsia prevention: some meta-analyses show large risk reduction; recent Cochrane-level reviews find none. evidence_strength: strong (heterogeneous), consensus: mixed [16][23][24].
• Population-wide DHA for child neurodevelopmental gains in non-deficient women: RCTs inconsistent. evidence_strength: moderate, consensus: mixed [21].
• Species-specific mercury/fish avoidance lists versus simplified "eat fish twice weekly" messaging. evidence_strength: moderate, consensus: mixed [30].

Unsupported / overstated:

• Maternal avoidance of allergenic foods as an allergy-prevention strategy — contradicted by current guidelines [41].
• High-dose omega-3 as uniformly beneficial — animal data show dose-dependent harm at excess intake [22].
• Reliance on unvalidated online NVP remedies over evidence-supported options (B6, ginger) [33][34].

6. Practical Clinical Applications

Universal: Folic acid 400 mcg/day preconception (4 mg/day if prior NTD, as a separate supplement) [6]; iodine ~150 µg/day, especially for vegetarian/vegan patients [16][17]; total alcohol abstinence [32]; caffeine ≤200 mg/day [31]; low-mercury fish 2–3 servings/week, avoiding king mackerel, swordfish, shark, tilefish, and bigeye tuna [30]; avoid unpasteurized dairy/soft cheeses, undercooked deli meats, and raw sprouts (listeria precautions); no allergenic-food restriction — plan infant introduction ~6 months [40][41].

Risk-stratified / context-dependent: Iron dosed by ferritin/hemoglobin — standard prenatal iron (~15–30 mg) is often insufficient for existing deficiency, requiring 40–60 mg/day elemental iron [11][14]. Calcium 1,500–2,000 mg/day with low dietary intake (500 mg/day emerging as a lower-cost alternative) [23][24]. Vitamin D 400–1,000 IU/day standard, higher supervised doses for GDM trials [16][19]. Omega-3/DHA ~200 mg/day for women with low fish intake, without promising neurodevelopmental gains [20][21]. Choline toward 450 mg/day via food (eggs) or supplement, since standard prenatal vitamins rarely contain it [18]. GWG counseled to IOM BMI-stratified targets with diet-quality/activity support [25]. GDM: MNT first-line, escalate to pharmacotherapy if glycemic targets unmet after 1–2 weeks [27][1]. Vegetarian/vegan: B12 non-negotiable; screen iron, iodine, choline, omega-3 [35][37].

Safety limits: Vitamin A >3,000 µg RAE/day is teratogenic (UL 2,700 µg RAE/day) [44]. Vitamin B6 for NVP: 1.3–1.4 mg/day RDA, 45 mg/day UL [33]. Sustained high folate (≥800 mcg/day absent high-risk indication) carries a GDM signal — avoid indiscriminate megadosing [9][6].

7. Clinical Pearls

• Folic acid works because it is taken before the patient knows she needs it — preconception counseling is the highest-leverage moment in this module.
• Fish is a benefit-risk tradeoff (DHA/iodine/selenium vs. methylmercury), not a simple "risky/safe" binary; blanket avoidance likely does more harm than good.
• Do not advise avoiding peanuts or eggs during pregnancy/breastfeeding to prevent infant allergy — current guidelines say the opposite.
• "Boosts baby's IQ" DHA marketing outstrips the RCT evidence; the trial-grade benefit is narrower (preterm birth in deficient women).
• Iodine and vitamin D both show U-shaped risk curves — more is not always better.
• Standard prenatal multivitamins often under-dose iron and omit choline — "she's on a prenatal vitamin" does not guarantee adequacy.

8. Common Misconceptions

• "Pregnant women must eat completely mercury-free." Evidence supports choosing low-mercury fish, not avoidance; total avoidance forfeits DHA, iodine, and selenium [30].
• "Avoiding peanuts/eggs protects the baby from allergies." Guidelines recommend the opposite — no maternal avoidance, early infant introduction [40][41].
• "More DHA is always better for brain development." Evidence shows a dose-sensitive, non-linear relationship with possible harm at excess [22].
• "A standard prenatal vitamin covers all needs." Iron and choline content are frequently inadequate [14][18].
• "A little alcohol is fine." No safe threshold has been established [32].

9. Summary

Pregnancy and lactation nutrition spans the strongest and weakest evidence this course covers, often for adjacent nutrients. Folic acid, iodine sufficiency, and alcohol abstinence are established and should be communicated with confidence. Iron, calcium, vitamin D, and MMS carry solid but heterogeneous evidence, generally justifying targeted use. Omega-3/DHA, choline, and many "prenatal superfood" claims remain probable-to-emerging — mechanistically plausible but not proven at the population level, and clinicians should say so rather than borrow folic acid's certainty to sell a DHA supplement. DOHaD ties this together: the intrauterine and lactation environment programs metabolic and neurodevelopmental trajectories persisting for decades. Calibrated, evidence-graded counseling — not blanket caution or blanket reassurance — is the skill this module builds.

10. References

Ordered by evidence strength / relevance. Evidence level and AllNutrition trust score (0–1) as returned by the tool.

1. How the First 9 Months Shape the Rest of Your Life: The Impact of Gestational Diabetes on the Metabolic Future. Diabetes, Obesity and Metabolism (2026). Review — trust 0.76.
2. Maternal Nutrition During Pregnancy and Fetal Outcome, Short- and Long-Term Health Effects: A Narrative Review. Nutrients (2026). Review — trust 0.737.
3. Interactions between nutrition and the epigenome: how can it be harnessed for public health? Future Science OA (2026). Review — trust 0.715.
4. Atherosclerosis as an evolutionary mismatch disease: from ancestral biology to cardiometabolic vulnerability. Current Problems in Cardiology (2026). Review — trust 0.762.
5. Maternal Nutrition and Hypothalamic Programming of Offspring Metabolic Health. The Journal of Nutrition (2026). Review — trust 0.765.
6. The Roles Of Folate, MTHFR Genetics, Vitamin B12 In Pregnancy Outcomes. Frontiers in Nutrition (2026). Review — trust 0.715.
7. The equity and effectiveness of China's 2009 folic acid supplementation programme for long-term child development. Global Health Action (2026). Observational — trust 0.863.
8. Prior Pregnancies Deplete Maternal Folate Status and Increase Risks of Neural Tube Defects in Addis Ababa, Ethiopia. The Journal of Nutrition (2026). Observational — trust 0.6.
9. Associations of folic acid supplements and dietary folate intake with gestational diabetes mellitus. Frontiers in Nutrition (2026). Observational — trust 0.722.
10. Effects of vitamin and multiple micronutrient supplementation for pregnant and/or lactating women on maternal and infant nutritional status in low- and middle-income countries: a systematic review and meta-analysis. Advances in Nutrition (2025). Systematic review — trust 0.892.
11. Impact of maternal micronutrient supplementation on pregnancy outcomes in developing countries: a systematic review and meta-analysis. BMC Pregnancy and Childbirth (2026). Systematic review — trust 0.825.
12. Early-pregnancy serum iron as a nutrition-related clinical laboratory indicator for preeclampsia risk stratification. Frontiers in Nutrition (2026). Observational — trust 0.77.
13. Effective Implementation Strategies for Delivering Nutritional Interventions through the Health System to Prevent Malnutrition during Pregnancy. Advances in Nutrition (2026). Systematic review — trust 0.877.
14. Maternal and infant serum ferritin concentrations across pregnancy and postpartum: a longitudinal study in Norway. Food & Nutrition Research (2026). Observational — trust 0.588.
15. Maternal Iodine Status During Pregnancy and Child Neurodevelopment: A Systematic Review and Dose–Response Meta-Analysis of Prospective Cohort Studies. Nutrients (2026). Systematic review — trust 0.815.
16. Iodine in Health and Disease: A Comprehensive Review. Nutrients (2026). Review — trust 0.695.
17. Modern challenges of iodine nutrition: vegan and vegetarian diets. Frontiers in Endocrinology (2025). Review — trust 0.705.
18. The role of choline in neurodevelopment. Pediatric Research (2026). Review — trust 0.688.
19. Effects of vitamin D supplementation on glucose metabolism and pregnancy outcomes in GDM: a systematic review and meta-analysis. Frontiers in Medicine (2026). Systematic review — trust 0.86.
20. Model-Based Cost-Effectiveness Analysis of Routine Omega-3 Testing and Targeted Supplementation to Reduce Early Preterm Birth in Australia. ClinicoEconomics and Outcomes Research (2026). Observational — trust 0.812.
21. Human milk omega-3 PUFA and infant neurodevelopment: Evidence and insights from Indian mothers. Prostaglandins, Leukotrienes and Essential Fatty Acids (2026). Review — trust 0.727.
22. High-dose prenatal omega-3 fish oil induces autism-like social deficits and hippocampal glial changes in rat offspring. Food and Chemical Toxicology (2026). Observational — trust 0.722.
23. Nutritional supplements for preventing preeclampsia: A network meta-analysis. Indian Journal of Medical Research (2025). Systematic review — trust 0.787.
24. Implementation Status of Low-Dose Aspirin and Calcium Supplementation to Prevent Preeclampsia in Burkina Faso, Ethiopia, Kenya, Nigeria and Pakistan. Maternal and Child Health Journal (2026). Observational — trust 0.8.
25. The effects of antenatal interventions on gestational weight gain in low and middle-income countries: a systematic review. BMJ Global Health (2026). Systematic review — trust 0.877.
26. Gestational weight gain outside the Institute of Medicine recommendations and adverse pregnancy outcomes: analysis using individual participant data from randomised trials. BMC Pregnancy and Childbirth (2019). RCT (IPD analysis) — trust 0.727.
27. Dietary intervention strategies for ethnic Chinese women with gestational diabetes mellitus: A systematic review and meta-analysis. Nutrition & Dietetics (2019). Systematic review — trust 0.72.
28. Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes. Diabetologia (2026). Observational — trust 0.787.
29. Neurodevelopmental effects of methylmercury (MeHg): a review of epidemiological points of departure, toxicological reference values, and key uncertainties. Archives of Toxicology (2026). Review — trust 0.75.
30. Lead and mercury exposure in pregnant women in the UK: a cross-sectional observational study (the PEAR Study). BMJ Open (2026). Observational — trust 0.613.
31. A Systematic Review of Studies Examining Associations between Sleep Characteristics with Dietary Intake and Eating Behaviors during Pregnancy. Nutrients (2023). Systematic review — trust 0.777.
32. Gender-specific gut microbiota alterations in adolescent C57BL/6 mice following prenatal alcohol exposure. Food and Chemical Toxicology (2026). Observational — trust 0.752.
33. YouTube as a source of (mis)information for morning sickness self-help. Midwifery (2026). Review — trust 0.725.
34. Efficacy of Different Nonpharmacological Interventions as Adjunctive Treatments for Postoperative Nausea and Vomiting: A Systematic Review and Bayesian Network Meta-analysis. Journal of PeriAnesthesia Nursing (2026). Systematic review — trust 0.818.
35. The Association of a Vegan Diet during Pregnancy with Maternal and Child Outcomes: A Systematic Review. Nutrients (2024). Systematic review — trust 0.802.
36. The Effects of Vegetarian and Vegan Diet during Pregnancy on the Health of Mothers and Offspring. Nutrients (2019). Review — trust 0.725.
37. The importance of vitamin B12 for individuals choosing plant-based diets. European Journal of Nutrition (2022). Review — trust 0.692.
38. Human milk microbiota: origins, determinants, and roles in maternal-infant microbial transmission and infant microbiome assembly. Frontiers in Microbiology (2026). Review — trust 0.912.
39. Factors That May Affect Breast Milk Macronutrient and Energy Content: A Critical Review. Nutrients (2025). Review — trust 0.738.
40. Parent-Reported Barriers and Facilitators to Early and Sustained Feeding of Allergenic Foods: A Mixed-Methods Systematic Review. Journal of Allergy and Clinical Immunology: In Practice (2026). Systematic review — trust 0.892.
41. Infant Feeding and Allergy Prevention. Australasian Society of Clinical Immunology and Allergy (ASCIA) (2020). Guideline — trust 0.83.
42. Nuts For Babies Study: protocol for a randomised controlled trial investigating maternal peanut/cashew diet during lactation. BMJ Open (2025). RCT — trust 0.777.
43. Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort Study. Allergy (2026). Observational — trust 0.802.
44. Hypervitaminosis: The deleterious effects of vitamins on the skin. Clinics in Dermatology (2026). Review — trust 0.7.
45. High-Dose Vitamin D3 Supplementation During Pregnancy and Test-Based Cognitive Performance at Age 10 Years: A Post Hoc Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open (2026). RCT — trust 0.853.
46. CastelLact Project: Exploring the Nutritional Status and Dietary Patterns of Pregnant and Lactating Women. Nutrients (2024). Observational — trust 0.727.

Supporting sources also surfaced: Community assessment of fish consumption and methylmercury exposure among Asian women of reproductive age in Chicago (J Exposure Sci Environ Epidemiol 2026, observational, trust 0.713); Maternal dietary vitamin A and PUFA intake and preterm birth risk (PeerJ 2026, observational, trust 0.787); Awareness and Use of Folic Acid Among Pregnant Women in Western Ukraine (IJERPH 2026, observational, trust 0.752); Omega-3 and omega-6 PUFA in neurodevelopment and prematurity: the Preterm PUFA Gap (Progress in Lipid Research 2026, review, trust 0.765).